AI and Big Data revolutionize local literature monitoring by enabling faster, more accurate detection of safety signals, improving drug safety and regulatory compliance worldwide.

AI-driven literature review streamlines pharmacovigilance by automating article screening, enhancing accuracy, accelerating signal detection, and ensuring regulatory compliance and patient safety.